Dihydroergotamine (Mesylate)
Overview
Categories
- 7 Antimigraine preparations
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Dihydroergotamine (Mesylate)'s dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 0.014 mg/kg | 0.014 (0.014) | As recommended. | IM | Maint, As Req, after 30-60 Min of the Initial Dose |
| 0.014 to 0.029 mg/kg | 0.021 (0.0215) | As recommended. | IM | Initially for Once |
| 0.014 mg/kg | 0.014 (0.014) | As recommended. | SC | Maint, As Req, after 30-60 Min of the Initial Dose |
| 0.014 to 0.029 mg/kg | 0.021 (0.0215) | As recommended. | SC | Initially for Once |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of Dihydroergotamine (Mesylate) is available. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Dihydroergotamine (Mesylate) is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Dihydroergotamine (Mesylate)
Back to top
Manufacturers of
Dihydroergotamine (Mesylate)
in Pakistan
Back to top
Previous Drug Generic - Next Drug Generic